Research Disclosures & Disclaimers

This website contains disclosures and disclaimers related to
published UBS Global Research products, including those related to
regulation, potential conflicts of interest as well as those provided
by third-party data providers describing limitations on use of their
products.

Walgreens Boots Alliance Inc (WBA.O)*

UBS Rating and Price Target History Chart

Line chart explaining Price target vs Stock Price is described in below table

EQ Rating & Price Target Table

Date Stock Price (US$) Price Target (US$) Rating
2022-03-1147.4454.00Neutral
2022-03-2247.4352.00Neutral
2022-04-0543.4949.00Neutral
2022-06-2742.1942.00Neutral
2022-07-0138.5640.00Neutral
2022-10-0730.5237.00Neutral
2022-11-2741.6640.00Neutral
2023-03-2232.5039.00Neutral
2023-03-2934.1537.00Neutral
2023-06-2631.5935.00Neutral
2023-06-3028.4932.00Neutral
2023-10-1022.3825.00Neutral
2024-04-0218.7222.00Neutral
2024-06-2115.9717.00Neutral
2024-07-0211.5712.00Neutral
2024-09-308.969.00Neutral
2024-10-1710.6610.00Neutral
2025-01-1311.9011.00Neutral
2025-03-0610.6011.45Neutral

Disclosures

  • UBS Securities LLC is acting as the Lead Financial Advisor and a Lead Financing Provider to Sycamore Partners on their announced take-private acquisition of Walgreens Boots Alliance Inc (NASDAQ: WBA).
  • UBS Securities LLC makes a market in the securities and/or ADRs of this company.
  • Because this security exhibits higher-than-average volatility, the FSR has been set at 15% above the MRA for a Buy rating, and at -15% below the MRA for a Sell rating (compared with 6/-6% under the normal rating system).
  • UBS holds a long or short position of 0.5% or more of the listed shares of this company.
Note : Historical Price Targets have been adjusted to account for any stock splits, rights issues and/or dividends which may have occurred for this security. Not Priced: Stock was not priced on the given date. No Rating: Issuer was not rated by UBS on the given day. No Price Target: For this issuer no Price Target was set by UBS on the given day. Issuers with an EQ Rating & Price Target Table are covered by UBS-IB Equity Research Analysts. Issuers without an EQ Rating & Price Target Table are not single stock covered.

* Issuers marked with an asterisk are covered by UBS-IB Equity Research Analysts. Issuers without an asterisk are not single stock covered.